Year |
Citation |
Score |
2020 |
Shaunfield S, Webster KA, Kaiser K, Greene GJ, Yount SE, Lacson L, Benson AB, Halperin DM, Yao JC, Singh S, Feuilly M, Marteau F, Cella D. Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index (FACT-CSI). Neuroendocrinology. PMID 32911478 DOI: 10.1159/000511482 |
0.316 |
|
2020 |
Peipert JD, Badawy SM, Baik SH, Oswald LB, Efficace F, Garcia SF, Mroczek DK, Wolf M, Kaiser K, Yanez B, Cella D. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS). Patient Preference and Adherence. 14: 971-983. PMID 32606615 DOI: 10.2147/Ppa.S249079 |
0.319 |
|
2020 |
Kaiser K, Yount SE, Martens CE, Webster KA, Shaunfield S, Sparling A, Peipert JD, Cella D, Rottinghaus ST, Donato BMK, Wells R, Tomazos I. Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ). Patient Preference and Adherence. 14: 705-715. PMID 32308375 DOI: 10.2147/Ppa.S233830 |
0.308 |
|
2020 |
Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World Journal of Gastrointestinal Oncology. 12: 205-218. PMID 32104551 DOI: 10.4251/Wjgo.V12.I2.205 |
0.387 |
|
2019 |
Silverberg JI, Lai JS, Kantor RW, Dalal P, Hickey C, Shaunfield S, Kaiser K, Correia H, Cella D. Development, validation and interpretation of the PROMIS Itch Questionnaire: a patient-reported outcome measure for the quality of life impact of itch. The Journal of Investigative Dermatology. PMID 31628927 DOI: 10.1016/J.Jid.2019.08.452 |
0.32 |
|
2019 |
Gross JP, Kruser JM, Moran MR, Kaiser K, Szmuilowicz E, Kircher SM, Kruser TJ. Radiation Oncologists' Role in End-Of-Life Care: A Perspective From Medical Oncologists. Practical Radiation Oncology. PMID 31202831 DOI: 10.1016/J.Prro.2019.04.001 |
0.307 |
|
2019 |
Kaiser K, Cameron KA, Beaumont J, Garcia SF, Lacson L, Moran M, Karavites L, Rodgers C, Kulkarni S, Hansen NM, Khan SA. What does risk of future cancer mean to breast cancer patients? Breast Cancer Research and Treatment. PMID 30840165 DOI: 10.1007/S10549-019-05182-3 |
0.363 |
|
2018 |
Silverberg JI, Kantor RW, Dalal P, Hickey C, Shaunfield S, Kaiser K, Lai JS, Cella D. A Comprehensive Conceptual Model of the Experience of Chronic Itch in Adults. American Journal of Clinical Dermatology. PMID 30155595 DOI: 10.1007/S40257-018-0381-6 |
0.303 |
|
2018 |
Kruser TJ, Kruser JM, Gross J, Moran M, Kaiser K, Szmuilowicz E, Kircher SM. Barriers to early integration of palliative care: A qualitative analysis of medical oncologist attitudes and practice patterns. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E22191 |
0.306 |
|
2017 |
Schifferdecker KE, Yount SE, Kaiser K, Adachi-Mejia A, Cella D, Carluzzo KL, Eisenstein A, Kallen MA, Greene GJ, Eton DT, Fisher ES. A method to create a standardized generic and condition-specific patient-reported outcome measure for patient care and healthcare improvement. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 28795261 DOI: 10.1007/S11136-017-1675-5 |
0.313 |
|
2016 |
Lai JS, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH, Chen SY. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clinical Rheumatology. PMID 27848056 DOI: 10.1007/S10067-016-3476-6 |
0.346 |
|
2016 |
Munoz AR, Kaiser K, Yanez B, Victorson D, Garcia SF, Snyder MA, Salsman JM. Cancer experiences and health-related quality of life among racial and ethnic minority survivors of young adult cancer: a mixed methods study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 27435322 DOI: 10.1007/S00520-016-3340-X |
0.336 |
|
2016 |
Yount SE, Beaumont JL, Chen SY, Kaiser K, Wortman K, Van Brunt DL, Swigris J, Cella D. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis. Lung. PMID 26861885 DOI: 10.1007/S00408-016-9850-Y |
0.324 |
|
2016 |
Kaiser K, Shaunfield S, Webster K, Keating K, Boyken L, Duffey S, Yarber J, Cella D. What Are the Most Important Symptoms and Concerns of Patients with Indolent Non-Hodgkin's Lymphoma? Content Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) Blood. 128: 4792-4792. DOI: 10.1182/Blood.V128.22.4792.4792 |
0.379 |
|
2016 |
Karavites L, Allu S, Khan S, Kaiser K. Abstract P6-12-13: Awareness and acceptability of skin application of preventive medications for breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-12-13 |
0.343 |
|
2015 |
Karavites LC, Allu S, Khan SA, Kaiser K. Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study. Bmc Cancer. 15: 878. PMID 26552376 DOI: 10.1186/S12885-015-1893-6 |
0.341 |
|
2015 |
Kaiser K, Beaumont JL, Webster K, Yount SE, Wagner LI, Kuzel TM, Cella D. Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale. Cancer Medicine. 4: 690-8. PMID 25619758 DOI: 10.1002/Cam4.385 |
0.353 |
|
2015 |
Jensen SE, Kaiser K, Lacson L, Schink J, Cella D. Content validity of the NCCN-FACT ovarian symptom index-18 (NFOSI-18). Gynecologic Oncology. 136: 317-22. PMID 25499602 DOI: 10.1016/J.Ygyno.2014.12.002 |
0.312 |
|
2015 |
Hahn EA, Segawa E, Kaiser K, Cella D, Smith BD. Validation of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E17753 |
0.338 |
|
2013 |
Kaiser K, Cameron KA, Curry G, Stolley M. Black women's awareness of breast cancer disparity and perceptions of the causes of disparity. Journal of Community Health. 38: 766-72. PMID 23539135 DOI: 10.1007/S10900-013-9677-X |
0.339 |
|
2013 |
Magasi S, Mallick R, Kaiser K, Patel JD, Lad T, Johnson ML, Kaplan EH, Cella D. Importance and relevance of pulmonary symptoms among patients receiving second- and third-line treatment for advanced non-small-cell lung cancer: support for the content validity of the 4-item Pulmonary Symptom Index. Clinical Lung Cancer. 14: 245-53. PMID 23036663 DOI: 10.1016/J.Cllc.2012.07.001 |
0.331 |
|
2013 |
Yount S, Kaiser K, Beaumont JL, Webster K, Wagner LI, Schenk TL, Kuzel T, Cella D. Development and validation of the functional assessment of cancer therapy: Antiangiogenesis (FACT-AntiA). Journal of Clinical Oncology. 31: e20527-e20527. DOI: 10.1200/Jco.2013.31.15_Suppl.E20527 |
0.382 |
|
2013 |
Butt Z, Mallick R, Mulcahy MF, Benson AB, Cella D, Kaiser K. Pain and other symptoms in patients with hepatocellular carcinoma (HCC): A qualitative analysis. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E15187 |
0.309 |
|
2013 |
Kaiser K, Cameron KA, Stolley M, Bethke KP, Hansen NM, Jeruss JS, Clayman ML, Khan SA. Breast cancer patients’ risk perceptions and treatment values following surgical consult. Journal of Clinical Oncology. 31: 36-36. DOI: 10.1200/Jco.2013.31.15_Suppl.E11572 |
0.365 |
|
2012 |
Kaiser K, Mallick R, Cella D. Key concerns and symptoms of patients undergoing second- and third-line treatment for non-small cell lung cancer: Findings from a patient interview study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 63. PMID 28147089 DOI: 10.1200/Jco.2012.30.34_Suppl.63 |
0.386 |
|
2012 |
Magasi S, Kaiser K, Mallick R, Cella D. Pulmonary symptoms and their importance to patients with non-small cell lung cancer undergoing second- and third-line chemotherapy. Journal of Clinical Oncology. 30: 9056-9056. DOI: 10.1200/Jco.2012.30.15_Suppl.9056 |
0.35 |
|
2012 |
Cella D, Kaiser K, Beaumont J, Diaz J, McCann L, Mehmud F, Lata S, Bono P, Porta C, Escudier B. Quality of Life (QOL) among Renal Cell Carcinoma (RCC) Patients in A Randomized Double Blind Cross-Over Patient Preference Study of Pazopanib (P) Versus Sunitinib (S) Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)33447-5 |
0.308 |
|
2011 |
Kaiser K, Rauscher GH, Jacobs EA, Strenski TA, Ferrans CE, Warnecke RB. The import of trust in regular providers to trust in cancer physicians among white, African American, and Hispanic breast cancer patients. Journal of General Internal Medicine. 26: 51-7. PMID 20811783 DOI: 10.1007/S11606-010-1489-4 |
0.38 |
|
2010 |
Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 640-7. PMID 20200436 DOI: 10.1158/1055-9965.Epi-09-0997 |
0.343 |
|
2009 |
Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, Studts JL, Bridges JF, Close DR, Erwin DO, Jones RM, Kaiser K, Kash KM, Kelly KM, Craddock Lee SJ, et al. Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3133-7. PMID 19900944 DOI: 10.1158/1055-9965.Epi-18-11-Aspo |
0.301 |
|
2008 |
Kaiser K. The meaning of the survivor identity for women with breast cancer. Social Science & Medicine (1982). 67: 79-87. PMID 18450347 DOI: 10.1016/J.Socscimed.2008.03.036 |
0.329 |
|
2004 |
McLeod JD, Kaiser K. Childhood emotional and behavioral problems and educational attainment American Sociological Review. 69: 636-658. DOI: 10.1177/000312240406900502 |
0.511 |
|
Show low-probability matches. |